Estradiol valerate
In addition to single-drug formulations, oral estradiol valerate is available in combination with the progestin dienogest as a combined oral contraceptive and intramuscular estradiol valerate is marketed in combination with the progestins hydroxyprogesterone caproate and norethisterone enantate as combined injectable contraceptives. Intramuscular estradiol valerate has also been marketed in combination with testosterone enantate, but this formulation has been discontinued. The availability of estradiol valerate-containing products varies throughout the world.
Estriol (medication)
Estriol is an estrogen, or an agonist of the estrogen receptors, ERα and ERβ. It has been found to possess 11–14% and 18–21% of the relative binding affinities of estradiol for the human ERα and ERβ, respectively, while its relative transactivational capacities at these receptors were 11% and 17%, respectively. In addition to being a ligand of the classical nuclear ERs, estriol is an antagonist of the GPER, a membrane estrogen receptor, at high concentrations. This is in contrast to estradiol, which is an agonist of this receptor. Like other estrogens, estriol does not importantly interact with other steroid hormone receptors.